THANK YOU FOR SUBSCRIBING
Bringing surgical oncologists an intelligent soft tissue marker named SmartClip™ and stereotactic surgical navigation to enable high-precision tumor site detection throughout the surgical removal procedure is Elucent Medical’s focus. Building the EnVisioTM Platform product with a focus on improving clinical outcomes for breast cancer patients, the technology is designed to offer similar surgical navigation used in other oncology specialties that guide oncologists in identifying the precise 3D location of soft tissue cancerous growth in real-time with a state-of-the-art surgical navigation system and precision-guided tools. “We’re enabling cancer surgeons to be more precise in their treatment and modernizing breast cancer care for the 21st century,” says Ginger Sands, Chief Customer Officer at Elucent Medical.
The company’s sophisticated surgical navigation technology is the result of its founder and CEO Laura King’s vision to empower physicians in designing state-of-the-art technology that addresses the real clinical needs. Thus, to improve physician and patient experience, Elucent Medical has developed an innovative solution to address what many surgeons across multiple specialities are facing – how to return to the exact location determined by radiologists who use high-tech, high-cost imaging technology to identify an area of concern.
To facilitate precise tumor removal, Elucent Medical’s patented Navigator fully integrates with standard hospital handheld electrosurgical tools and displays its movements in real-time on the EnVisioTM Navigation system’s monitor. Aided by the 3D analytical image showcasing the precise location of the SmartClipTM embedded in the tumor, the Navigator enables surgeons to perform minimally invasive surgeries to remove only the cancerous cells, leaving more of healthier tissues intact.
Dr. Richard Bleicher of Fox Chase Cancer Center shares, “Elucent Medical’s advanced surgical navigation technology not only eliminates any guesswork on the surgeons’ part, but also removes the need for additional imaging during surgery. Simultaneously, it contributes to faster tumor removal and quicker patient recovery times with minimal scarring.’’ In a nutshell, Elucent Medical’s technology provides a better experience for both patients and surgeons by significantly reducing repeat surgery rates and diminishing healthcare costs in the long run.
Share this Article:
Tweet
|
Company
Elucent Medical
Headquarters
Eden Prairie, MN
Management
Ginger Sands, Chief Customer Officer, Elucent Medical
Description
Elucent Medical provides advanced surgical navigation technology to precisely locate soft tissue cancerous growth in real-time during surgery. The company offers surgical oncologists an intelligent soft tissue marker SmartClip™ and stereotactic surgical navigation to enable high-precision tumor site detection throughout the surgical removal procedure. The company’s EnVisioTM Platform technology improves clinical outcomes for breast cancer patients and is designed to offer similar surgical navigation used in other oncology specialties that guide oncologists in identifying the precise 3D location of the cancerous growth with the state-of-the-art surgical navigation system and precision-guided tools.